Recital 40, Regulation (EU) 2026/372

In forcesince 20 Feb 2026

The risk assessments pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 for 1-naphthylacetamide, 1-naphthylacetic acid, esfenvalerate, fluazifop-P, pyridaben and spiroxamine have not yet been finalised by the rapporteur Member States and additional time is required to complete the remaining steps in each renewal procedure.

  • celex=32012R0844